CUE logo

Cue Biopharma (CUE) Total Liabilities

Annual Total Liabilities

$24.45 M
-$1.16 M-4.52%

December 31, 2023


Summary


Performance

CUE Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCUEbalance sheetmetrics:

Quarterly Total Liabilities

$19.44 M
-$1.26 M-6.10%

September 30, 2024


Summary


Performance

CUE Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCUEbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

CUE Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.5%-6.1%
3 y3 years+18.5%-24.1%
5 y5 years+114.6%-24.1%

CUE Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-4.5%+36.5%-28.4%+8.6%
5 y5-year-4.5%+43.6%-28.4%+26.6%
alltimeall time-4.5%+6396.1%-28.4%+1661.2%

Cue Biopharma Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$19.44 M(-6.1%)
Jun 2024
-
$20.71 M(-13.4%)
Mar 2024
-
$23.91 M(-2.2%)
Dec 2023
$24.45 M(-4.5%)
$24.45 M(-6.8%)
Sep 2023
-
$26.22 M(-3.5%)
Jun 2023
-
$27.16 M(+1.9%)
Mar 2023
-
$26.66 M(+4.2%)
Dec 2022
$25.60 M(+43.0%)
$25.60 M(+0.3%)
Sep 2022
-
$25.54 M(+2.2%)
Jun 2022
-
$24.99 M(-4.0%)
Mar 2022
-
$26.03 M(+45.4%)
Dec 2021
$17.91 M(-13.2%)
$17.91 M(+16.6%)
Sep 2021
-
$15.36 M(-8.4%)
Jun 2021
-
$16.76 M(-12.0%)
Mar 2021
-
$19.05 M(-7.6%)
Dec 2020
$20.62 M
$20.62 M(+8.2%)
DateAnnualQuarterly
Sep 2020
-
$19.06 M(-10.1%)
Jun 2020
-
$21.20 M(+37.5%)
Mar 2020
-
$15.41 M(-9.4%)
Dec 2019
$17.02 M(+49.4%)
$17.02 M(-6.4%)
Sep 2019
-
$18.19 M(-15.3%)
Jun 2019
-
$21.48 M(+5.0%)
Mar 2019
-
$20.45 M(+79.5%)
Dec 2018
$11.39 M(+113.1%)
$11.39 M(+120.0%)
Sep 2018
-
$5.18 M(+33.4%)
Jun 2018
-
$3.88 M(-4.9%)
Mar 2018
-
$4.08 M(-23.6%)
Dec 2017
$5.35 M(+384.3%)
$5.35 M(+179.2%)
Sep 2017
-
$1.91 M(+21.2%)
Jun 2017
-
$1.58 M(+43.1%)
Dec 2016
$1.10 M(+193.4%)
$1.10 M
Dec 2015
$376.30 K
-

FAQ

  • What is Cue Biopharma annual total liabilities?
  • What is the all time high annual total liabilities for Cue Biopharma?
  • What is Cue Biopharma annual total liabilities year-on-year change?
  • What is Cue Biopharma quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Cue Biopharma?
  • What is Cue Biopharma quarterly total liabilities year-on-year change?

What is Cue Biopharma annual total liabilities?

The current annual total liabilities of CUE is $24.45 M

What is the all time high annual total liabilities for Cue Biopharma?

Cue Biopharma all-time high annual total liabilities is $25.60 M

What is Cue Biopharma annual total liabilities year-on-year change?

Over the past year, CUE annual total liabilities has changed by -$1.16 M (-4.52%)

What is Cue Biopharma quarterly total liabilities?

The current quarterly total liabilities of CUE is $19.44 M

What is the all time high quarterly total liabilities for Cue Biopharma?

Cue Biopharma all-time high quarterly total liabilities is $27.16 M

What is Cue Biopharma quarterly total liabilities year-on-year change?

Over the past year, CUE quarterly total liabilities has changed by -$1.26 M (-6.10%)